Skin penetration of topical formulations of ibuprofen 5%: An in vitro comparative study

Skin Pharmacology and Applied Skin Physiology

Volumn 16, Issue 3, 2003, Pages 137-142

  Hadgraft, J ^a   Whitefield, M ^b   Rosher, P H ^b  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b Dermal Laboratories Ltd   (United Kingdom)

Author keywords

Formulations; Ibuprofen; NSAIDs; Skin penetration; Topical

Indexed keywords

DEEP RELIEF; IBUMOUSSE; IBUPROFEN; IBUSPRAY;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DIFFUSION; DRUG FORMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; SKIN PENETRATION;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; FEMALE; GELS; HUMANS; IBUPROFEN; MALE; OINTMENTS; SKIN; SKIN ABSORPTION; TIME FACTORS;

EID: 0037251396     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069759     Document Type: Article

References (8)

1. Wester RC, Maibach HI: Percutaneous absorption of drugs. Clin Pharmacokinet 1992;23:253-266.
2. Gabard B, Treffel P: Correlation of in vitro and in vivo testing. Curr Probl Dermatol 1998;26:217-222.
3. Treffel P, Gabard B: Feasibility of measuring the bioavailability of topical ibuprofen in commercial formulations using drug content in epidermis and a methyl nicotinate skin inflammation assay. Skin Pharmacol 1993;6:268-275.
4. Skelly JP, Shah VP, Maibach HI, et al: FDA and AAPS report of the Workshop on Principles and Practices of in vitro Percutaneous Penetration Studies: Relevance to bio-availability and bioequivalence. Pharm Res 1987;4:265-267.
5. Franz TJ: The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man. Curr Probl Dermatol 1978;7:58-68.
6. Hadgraft J, Valenta C: pH, pKa and dermal delivery. Int J Pharm 2000;200:243-247.
7. Brain KR, Hadgraft J, James VJ, et al: In vitro assessment of skin permeation from a transdermal system for the delivery of oestradiol. Int J Pharm 1993;89:R13-R16.
8. Hadgraft J, Lewis D, Beutner D, et al: In vitro-in vivo correlations in transdermal nitroglycerin delivery; in Scott RC, Guy HR, Hadgraft J, Bodde HE (eds): Prediction of Percutaneous Penetration. London, IBC Technical Services, 1991, vol 2, pp 315-322.